CN108210657A - A kind of Chinese medicine composition for preventing and treating lung cancer - Google Patents
A kind of Chinese medicine composition for preventing and treating lung cancer Download PDFInfo
- Publication number
- CN108210657A CN108210657A CN201611176570.1A CN201611176570A CN108210657A CN 108210657 A CN108210657 A CN 108210657A CN 201611176570 A CN201611176570 A CN 201611176570A CN 108210657 A CN108210657 A CN 108210657A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- root
- myrobalan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 84
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 12
- 201000005202 lung cancer Diseases 0.000 title claims abstract description 12
- 208000020816 lung neoplasm Diseases 0.000 title claims abstract description 12
- 241001165494 Rhodiola Species 0.000 claims abstract description 33
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 31
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 28
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 27
- 235000001971 Pulmonaria saccharata Nutrition 0.000 claims abstract description 25
- 235000011293 Brassica napus Nutrition 0.000 claims abstract description 24
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 claims abstract description 24
- 241000229143 Hippophae Species 0.000 claims abstract description 24
- 235000003935 Hippophae Nutrition 0.000 claims abstract description 23
- 235000011517 Terminalia chebula Nutrition 0.000 claims abstract description 23
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 22
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 22
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 22
- 240000004980 Rheum officinale Species 0.000 claims abstract description 22
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 22
- 244000089698 Zanthoxylum simulans Species 0.000 claims abstract description 20
- ALHUZKCOMYUFRB-UHFFFAOYSA-N muskone Natural products CC1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-UHFFFAOYSA-N 0.000 claims abstract description 20
- ALHUZKCOMYUFRB-OAHLLOKOSA-N Muscone Chemical compound C[C@@H]1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-OAHLLOKOSA-N 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 244000146438 Pulmonaria saccharata Species 0.000 claims abstract 6
- 240000002791 Brassica napus Species 0.000 claims abstract 3
- 244000119298 Emblica officinalis Species 0.000 claims description 31
- 235000013399 edible fruits Nutrition 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 241000742376 Swertia patens Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 6
- 235000015468 Lycium chinense Nutrition 0.000 claims description 4
- 244000241872 Lycium chinense Species 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 240000006698 Spigelia anthelmia Species 0.000 claims 3
- 235000013402 health food Nutrition 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 27
- 244000277583 Terminalia catappa Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 30
- 240000008100 Brassica rapa Species 0.000 description 23
- 241001303775 Phlomis Species 0.000 description 19
- 229940079593 drug Drugs 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 201000010099 disease Diseases 0.000 description 17
- 210000004072 lung Anatomy 0.000 description 16
- 239000000796 flavoring agent Substances 0.000 description 15
- 235000019634 flavors Nutrition 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 14
- 206010011224 Cough Diseases 0.000 description 13
- 239000004480 active ingredient Substances 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 6
- -1 Thio glucose glucosides Chemical class 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 229940046011 buccal tablet Drugs 0.000 description 5
- 239000006189 buccal tablet Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 244000205574 Acorus calamus Species 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 244000153234 Hibiscus abelmoschus Species 0.000 description 4
- 244000241838 Lycium barbarum Species 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- XOXYHGOIRWABTC-UHFFFAOYSA-N gentisin Chemical compound C1=C(O)C=C2C(=O)C3=C(O)C=C(OC)C=C3OC2=C1 XOXYHGOIRWABTC-UHFFFAOYSA-N 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 235000011996 Calamus deerratus Nutrition 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 241000699660 Mus musculus Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 244000000231 Sesamum indicum Species 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 235000006533 astragalus Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- 238000011580 nude mouse model Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 230000005070 ripening Effects 0.000 description 3
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- UQSRXQMIXSZGLA-UHFFFAOYSA-N 2,4-dihydroxy-6-methylbenzoic acid ethyl ester Chemical compound CCOC(=O)C1=C(C)C=C(O)C=C1O UQSRXQMIXSZGLA-UHFFFAOYSA-N 0.000 description 2
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- OIGWAXDAPKFNCQ-UHFFFAOYSA-N 4-isopropylbenzyl alcohol Chemical compound CC(C)C1=CC=C(CO)C=C1 OIGWAXDAPKFNCQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- NMKBRSYSHBPUPY-UHFFFAOYSA-N Barbatic acid Chemical compound OC1=C(C)C(OC)=CC(C)=C1C(=O)OC1=CC(C)=C(C(O)=O)C(O)=C1C NMKBRSYSHBPUPY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 244000260524 Chrysanthemum balsamita Species 0.000 description 2
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 2
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 2
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 2
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- PGCKDCPTJAQQSQ-UHFFFAOYSA-N Isolicoflavonol Chemical compound C1=C(O)C(CC=C(C)C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 PGCKDCPTJAQQSQ-UHFFFAOYSA-N 0.000 description 2
- 235000009421 Myristica fragrans Nutrition 0.000 description 2
- 244000270834 Myristica fragrans Species 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000222341 Polyporaceae Species 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000301399 Trogopterus xanthipes Species 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 2
- RKFAZBXYICVSKP-AATRIKPKSA-N alpha-asarone Chemical group COC1=CC(OC)=C(\C=C\C)C=C1OC RKFAZBXYICVSKP-AATRIKPKSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- MPXAWSABMVLIBU-UHFFFAOYSA-N bellidin Chemical compound C1=CC(O)=C2C(=O)C3=C(O)C=C(O)C=C3OC2=C1O MPXAWSABMVLIBU-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- LIMQQADUEULBSO-UHFFFAOYSA-N butyl isothiocyanate Chemical compound CCCCN=C=S LIMQQADUEULBSO-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- UGIVASYMZSZAMP-UHFFFAOYSA-N chebulagic acid Natural products OC1C2c3c(OC1=O)c(O)c(O)cc3C(=O)OC4C(OC(=O)c5cc(O)c(O)c(O)c5)OC6COC(=O)c7cc(O)c(O)c(O)c7c8c(O)c(O)c(O)cc8C(=O)OC4C6OC(=O)C2(O)C(=O)O UGIVASYMZSZAMP-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 2
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 208000037841 lung tumor Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 239000001702 nutmeg Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- NCCWCZLEACWJIN-UHFFFAOYSA-N orsellinic acid methyl ester Chemical compound COC(=O)C1=C(C)C=C(O)C=C1O NCCWCZLEACWJIN-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- SGAWOGXMMPSZPB-UHFFFAOYSA-N safranal Chemical compound CC1=C(C=O)C(C)(C)CC=C1 SGAWOGXMMPSZPB-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 150000008130 triterpenoid saponins Chemical class 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- WEYVVCKOOFYHRW-SFHVURJKSA-N (+)-usnic acid Chemical compound O=C([C@@]12C)C(C(=O)C)=C(O)C=C1OC1=C2C(O)=C(C)C(O)=C1C(C)=O WEYVVCKOOFYHRW-SFHVURJKSA-N 0.000 description 1
- KGAGLTSPYLYTGL-UHFFFAOYSA-N (+)-usnic acid Natural products COc1c(O)c(C)c(O)c2c1OC3=CC(=C(C(=O)C)C(=O)C23C)O KGAGLTSPYLYTGL-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- IMNKABOILQOFDL-UHFFFAOYSA-N (-Muscopyridine Natural products C1C(C)CCCCCCCCC2=CC=CC1=N2 IMNKABOILQOFDL-UHFFFAOYSA-N 0.000 description 1
- IMNKABOILQOFDL-CQSZACIVSA-N (10r)-10-methyl-16-azabicyclo[10.3.1]hexadeca-1(16),12,14-triene Chemical compound C1[C@H](C)CCCCCCCCC2=CC=CC1=N2 IMNKABOILQOFDL-CQSZACIVSA-N 0.000 description 1
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- RETRVWFVEFCGOK-RMKNXTFCSA-N (e)-3-(3,4-dihydroxy-2-methoxyphenyl)-1-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one Chemical compound COC1=C(O)C(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C(CC=C(C)C)=C1 RETRVWFVEFCGOK-RMKNXTFCSA-N 0.000 description 1
- YGVHOSGNOYKRIH-UHFFFAOYSA-N 1,3,6-tri-O-galloyl-2,4-O-chebuloyl-beta-D-glucopyranose Natural products O1C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(C2OC(=O)C=3C=C(O)C(O)=C(O)C=3)OC(=O)C(C3=4)=CC(O)=C(O)C=4OC(=O)C(O)C3C(CC(O)=O)C(=O)OC2C1COC(=O)C1=CC(O)=C(O)C(O)=C1 YGVHOSGNOYKRIH-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- SWWQQSDRUYSMAR-UHFFFAOYSA-N 1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol;hydrochloride Chemical group Cl.C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 SWWQQSDRUYSMAR-UHFFFAOYSA-N 0.000 description 1
- FLNXBVJLPJNOSI-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 FLNXBVJLPJNOSI-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- ODBRNZZJSYPIDI-UHFFFAOYSA-N 3',4',5,7-tetrahydroxy-6-C-glucopyranosylflavone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ODBRNZZJSYPIDI-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- JCGXIYQLRYPHDG-DQOTWGJISA-N 30-hydroxy-11-oxo-beta-amyrin Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(CO)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C JCGXIYQLRYPHDG-DQOTWGJISA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 101800000263 Acidic protein Proteins 0.000 description 1
- 235000006480 Acorus calamus Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011297 Brassica napobrassica Nutrition 0.000 description 1
- 241000219192 Brassica napus subsp. rapifera Species 0.000 description 1
- 244000304217 Brassica oleracea var. gongylodes Species 0.000 description 1
- 235000011292 Brassica rapa Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- HGJXAVROWQLCTP-YABCKIEDSA-N Chebulagic acid Chemical compound O([C@H]1[C@H]2[C@H]3OC(=O)C4=CC(O)=C(O)C(O)=C4C4=C(O)C(O)=C(O)C=C4C(=O)OC[C@@H](O1)[C@H]3OC(=O)[C@@H](CC(O)=O)[C@@H]1[C@@H](C(OC=3C(O)=C(O)C=C(C1=3)C(=O)O2)=O)O)C(=O)C1=CC(O)=C(O)C(O)=C1 HGJXAVROWQLCTP-YABCKIEDSA-N 0.000 description 1
- 229920002052 Chebulagic acid Polymers 0.000 description 1
- YGVHOSGNOYKRIH-FJPMMHPYSA-N Chebulinic acid Chemical compound C([C@@H]1[C@H]2OC(=O)[C@@H](CC(O)=O)[C@@H]3[C@@H](C(OC=4C(O)=C(O)C=C(C3=4)C(=O)O[C@@H]([C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)O1)[C@H]2OC(=O)C=1C=C(O)C(O)=C(O)C=1)=O)O)OC(=O)C1=CC(O)=C(O)C(O)=C1 YGVHOSGNOYKRIH-FJPMMHPYSA-N 0.000 description 1
- 229920000585 Chebulinic acid Polymers 0.000 description 1
- MHDANAFDVQLLPY-UHFFFAOYSA-N Chebulinic acid Natural products OC(C1C(CC(=O)O)C(=O)OC2C(COC(=O)c3cc(O)c(O)c(O)c3)OC(OC(=O)c4cc(O)c(O)c(O)c4)C(OC(=O)c5cc(O)c(O)c(O)c15)C2OC(=O)c6cc(O)c(O)c(O)c6)C(=O)O MHDANAFDVQLLPY-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- 208000031973 Conjunctivitis infective Diseases 0.000 description 1
- 229920002786 Corilagin Polymers 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- LZBXPXAOYQVZEC-RIYZIHGNSA-N Dendrolasin Chemical compound CC(C)=CCC\C(C)=C\CCC=1C=COC=1 LZBXPXAOYQVZEC-RIYZIHGNSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- PLAPMLGJVGLZOV-UHFFFAOYSA-N Epi-orientin Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 108010023832 Florigen Proteins 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 241000246500 Gentianella aspera Species 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- QOEHNLSDMADWEF-UHFFFAOYSA-N I-Dotriacontanol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO QOEHNLSDMADWEF-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 1
- RETRVWFVEFCGOK-UHFFFAOYSA-N Licochalcone D Natural products COC1=C(O)C(O)=CC=C1C=CC(=O)C1=CC=C(O)C(CC=C(C)C)=C1 RETRVWFVEFCGOK-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- UUQHKWMIDYRWHH-UHFFFAOYSA-N Methyl beta-orcinolcarboxylate Chemical class COC(=O)C1=C(C)C=C(O)C(C)=C1O UUQHKWMIDYRWHH-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241001233983 Orychophragmus violaceus Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000399256 Pteromyini Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000220287 Sedum rubrotinctum Species 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000974657 Swertia pseudochinensis Species 0.000 description 1
- OZWDYLLMBFLSNH-UHFFFAOYSA-N Swertisin Natural products COc1cc2OC(=CC(=O)c2c(O)c1OC3OC(CO)C(O)C(O)C3O)c4cccc(O)c4 OZWDYLLMBFLSNH-UHFFFAOYSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 241000032846 Zanthoxylum bungeanum Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000016720 allyl isothiocyanate Nutrition 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 150000001440 androstane derivatives Chemical class 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000001887 anti-feedant effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- RKFAZBXYICVSKP-UHFFFAOYSA-N beta- asarone Natural products COC1=CC(OC)=C(C=CC)C=C1OC RKFAZBXYICVSKP-UHFFFAOYSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- RKFAZBXYICVSKP-WAYWQWQTSA-N beta-asarone Chemical compound COC1=CC(OC)=C(\C=C/C)C=C1OC RKFAZBXYICVSKP-WAYWQWQTSA-N 0.000 description 1
- ZHKVKULEJZXSLW-KZZGZOJNSA-N beta-daucosterol Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(O)[C@H]3CC[C@]12C)O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C ZHKVKULEJZXSLW-KZZGZOJNSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- PJWPOUFMMWFJOL-UHFFFAOYSA-N beta-sitosterol-beta-D-glucoside Natural products CCC(CCC(C)C1CCC2C3C=CC4CC(CCC4(C)C3CCC12C)OC5OC(CO)C(O)C(O)C5O)C(C)C PJWPOUFMMWFJOL-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000003098 cholesteric effect Effects 0.000 description 1
- 229960002544 cloperastine Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- TUSDEZXZIZRFGC-XIGLUPEJSA-N corilagin Chemical compound O([C@H]1[C@H](O)[C@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC[C@@H](O1)[C@H]2O)C(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-XIGLUPEJSA-N 0.000 description 1
- CPWYQGWOJMNXGJ-UHFFFAOYSA-N corilagin Natural products OC1C2COC(=O)c3c(O)c(O)c(O)c(O)c3c4c(O)c(O)c(O)c(O)c4C(=O)OC1C(O)C(OC(=O)c5cc(O)c(O)c(O)c5)O2 CPWYQGWOJMNXGJ-UHFFFAOYSA-N 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 239000001209 crocus sativus l. Substances 0.000 description 1
- CGZZMOTZOONQIA-UHFFFAOYSA-N cycloheptanone Chemical compound O=C1CCCCCC1 CGZZMOTZOONQIA-UHFFFAOYSA-N 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- LZBXPXAOYQVZEC-UHFFFAOYSA-N dendrolasin Natural products CC(C)=CCCC(C)=CCCC=1C=COC=1 LZBXPXAOYQVZEC-UHFFFAOYSA-N 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229940108623 eicosenoic acid Drugs 0.000 description 1
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000001261 florigenic effect Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- DFNZYFAJQPLJFI-UHFFFAOYSA-N gentianine Chemical compound O=C1OCCC2=C1C=NC=C2C=C DFNZYFAJQPLJFI-UHFFFAOYSA-N 0.000 description 1
- 239000008125 glucin Substances 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- JCGXIYQLRYPHDG-UHFFFAOYSA-N glycyrrhetol Natural products C12C(=O)C=C3C4CC(C)(CO)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C JCGXIYQLRYPHDG-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- ODBRNZZJSYPIDI-VJXVFPJBSA-N isoorientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ODBRNZZJSYPIDI-VJXVFPJBSA-N 0.000 description 1
- UYJGIAWJIRZBNU-UHFFFAOYSA-N isoorientin Natural products OCC1OC(C(O)C(O)C1O)c2cc(O)c(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4 UYJGIAWJIRZBNU-UHFFFAOYSA-N 0.000 description 1
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 1
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- PEFNSGRTCBGNAN-UHFFFAOYSA-N nephrocizin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-UHFFFAOYSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000017509 safranal Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 150000003429 steroid acids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- ABRULANJVVJLFI-DGHBBABESA-N swertisin Chemical compound COC1=CC=2OC(C=3C=CC(O)=CC=3)=CC(=O)C=2C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ABRULANJVVJLFI-DGHBBABESA-N 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- NUPTUAXNMUIMFS-MIHIQLSESA-N terchebin Chemical compound C([C@@H]1[C@H]2OC(=O)C=3[C@H]4C5=C(C(O[C@@H]([C@H](OC(=O)C=6C=C(O)C(O)=C(O)C=6)O1)[C@H]2OC(=O)C=1C=C(O)C(O)=C(O)C=1)=O)C=C(C(=C5OC4(O)C(O)(O)C(=O)C=3)O)O)OC(=O)C1=CC(O)=C(O)C(O)=C1 NUPTUAXNMUIMFS-MIHIQLSESA-N 0.000 description 1
- ULYXEEKCDUUGNM-UHFFFAOYSA-N terchebin Natural products Oc1cc(cc(O)c1O)C(=O)OCC2OC(OC(=O)c3cc(O)c(O)c(O)c3)C4OC(=O)C5CC(=O)C(=O)C(=O)C5c6c(O)c(O)c(O)cc6C(=O)OC2C4OC(=O)c7cc(O)c(O)c(O)c7 ULYXEEKCDUUGNM-UHFFFAOYSA-N 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 235000004330 tyrosol Nutrition 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- ICTZCAHDGHPRQR-UHFFFAOYSA-N usnic acid Natural products OC1=C(C)C(O)=C(C(C)=O)C2=C1C1(C)C(O)=C(C(=O)C)C(=O)C=C1O2 ICTZCAHDGHPRQR-UHFFFAOYSA-N 0.000 description 1
- WEYVVCKOOFYHRW-UHFFFAOYSA-N usninic acid Natural products CC12C(=O)C(C(=O)C)=C(O)C=C1OC1=C2C(O)=C(C)C(O)=C1C(C)=O WEYVVCKOOFYHRW-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 150000007964 xanthones Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/09—Lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a kind of Chinese medicine compositions for preventing and treating lung cancer, include the raw material of following weight:1 30 parts of turnip, 10 40 parts of excrementum pteropi, 20 60 parts of myrobalan, 1 30 parts of rheum officinale, 1 30 parts of rhodiola root, 1 30 parts of Rhizoma Acori Calami, 1 30 parts of cordyceps sinensis, 0.1 15 parts of west safflower, 0.1 10 parts of long sunglo, 0.1 10 parts of Fructus Hippophae extractum, 0.1 10 parts of younghusband jerusalemsage root, 0.1 15 parts of Radix Glycyrrhizae and selected from least one of 0.1 20 parts of Chinese prickly ash, 0.1 20 parts of ganoderma lucidum, 0.1 2 parts of muscone.The present invention can effectively inhibit, eliminate tumour, improve the life quality of patient.
Description
Technical field:
The present invention relates to a kind of Chinese medicine preparations for treating lung tumors, belong to technical field of traditional Chinese medicines.
Background technology
At present, lung cancer is that morbidity and mortality growth is most fast, the life and health of serious threat people, lung in global range
The incidence of cancer remains high, and is the highest disease of morbidity and mortality in tumour.Because lung cancer morbidity is fast, many patients are true
Operation excision is unconditionally carried out after examining.And use transmitting sex therapy and chemotherapy larger to the side effect of human body, patient
Generally require to suffer exquisite pain, and treat after along with body immunity decline, after treatment life quality decline the problems such as,
The compliance of patient is bad.
This year, country increase the input to traditional Chinese medicine, more and more prescriptions of traditional Chinese medicine for having good efficacy for tumour
It is found.For the medicine that compares, traditional Chinese medicine such as stablizes knurl stove, elongated strap knurl life span, increases body and exempt from all various aspects
Epidemic disease function, the life quality for improving patient, improvement clinical condition etc. have certain advantage.
The present invention is to use Chinese medicine as raw material, according to the Chinese prescription of traditional medicine theoretical informatics, with reference to modern system
Traditional Chinese medicine lozenge is made in agent technique.
Tibetanmedicine thinks that human body is made of " grand, red bar, Baconic " three big basis.The root of all diseases is all
" grand, red bar, Baconic's " is unbalance and disorderly.Under normal circumstances, it is grand to occupy bone;Red bar occupy blood, sweat;Baconic, which occupy, to be removed
Other positions except bone, blood, sweat, i.e. essence, muscle, fat, marrow, sperm, stool, urine etc..Tibetan medicine thinks
Under normal condition, object of ingesting supports " first liquid ", first liquid nutrition blood, hemotrophic nutrition soft tissue meat, meat nutrient fat tissue, fat
Fat nutrition bone tissue, osteotrophy marrow.The disorder being formed as between three of tumour causes ingested object to fail to turn to " just
Liquid ", and be turned into " dislike liquid " and intravascular enters whole body and respectively organizes, and at the weak position of a certain immunity function, by grand knot
Structure element shakes, hard, thin, cold, light, thick reverse action shrinks the lump built up and disappeared for hard difficulty.This lump like as blueness shoulders fruit stone
Tibetan medicine is referred to as " stagnant cancer ", can be translated as " core " from literal, and i.e. modern medicine is referred to as the disease of tumour for this.
Patient's pulse condition string is thin, power is small and micro-, and the general arteries and veins up and down that controls is other than micro- show, and unobvious are hollow pulse, and ruffian knurl exists
The dirty specific pulse condition unobvious at which of each internal organs but into a piece of bounce;Go out the point of present situation such as fish purpose ruffian knurl in urine
Drop;Occur different color in up and down before this, be Baconic when having the position white of ruffian knurl, when yellow is red bar, is when red
Blood etc.;Any part of body with ruffian knurl, at this above slightly contamination dirt.
Invention content
The present invention provides a kind of compound preparations being made of traditional herbal medicines.Said preparation can effectively inhibit patients with lung cancer
The growth of tumour improves the life quality of patient.
A kind of Chinese medicine composition for treating lung cancer includes the raw material of following weight:1-30 parts of turnip, excrementum pteropi
10-40 parts, it is 20-60 parts of myrobalan, 1-30 parts of rheum officinale, 1-30 parts of rhodiola root, 1-30 parts of Rhizoma Acori Calami, 1-30 parts of cordyceps sinensis, western red
0.1-15 parts of flower, 0.1-10 parts of younghusband jerusalemsage root, 0.1-15 parts of Radix Glycyrrhizae and is selected from sunglo 0.1-10 parts long, 0.1-10 parts of Fructus Hippophae extractum
At least one of 0.1-20 parts of Chinese prickly ash, 0.1-20 parts of ganoderma lucidum, 0.1-2 parts of muscone.
Further, the Chinese medicine composition includes the raw material of following weight:1-30 parts of turnip, excrementum pteropi 10-
40 parts, 20-60 parts of myrobalan, 1-30 parts of rheum officinale, 1-30 parts of rhodiola root, 1-30 parts of Rhizoma Acori Calami, 1-30 parts of cordyceps sinensis, west safflower
0.1-15 parts, sunglo 0.1-10 parts long, 0.1-10 parts of Fructus Hippophae extractum, 0.1-10 parts of younghusband jerusalemsage root, 0.1-15 parts of Radix Glycyrrhizae and selected from flower
At least two in 0.1-20 parts of green pepper, 0.1-20 parts of ganoderma lucidum, 0.1-2 parts of muscone.
Further, the Chinese medicine composition includes the raw material of following weight:1-30 parts of turnip, excrementum pteropi 10-
40 parts, 20-60 parts of myrobalan, 1-30 parts of rheum officinale, 1-30 parts of rhodiola root, 1-30 parts of Rhizoma Acori Calami, 1-30 parts of cordyceps sinensis, west safflower
0.1-15 parts, sunglo 0.1-10 parts long, 0.1-10 parts of Fructus Hippophae extractum, 0.1-10 parts of younghusband jerusalemsage root, 0.1-15 parts of Radix Glycyrrhizae, Chinese prickly ash 0.1-20
Part, 0.1-20 parts of ganoderma lucidum, 0.1-2 parts of muscone.
Further, the Chinese medicine composition includes the raw material of following weight:10-20 parts of turnip, excrementum pteropi 20-
35 parts, 35-50 parts of myrobalan, 1-15 parts of rheum officinale, 1-10 parts of rhodiola root, 1-10 parts of Rhizoma Acori Calami, 1-10 parts of cordyceps sinensis, west safflower
0.1-5 parts, sunglo 0.1-5 parts long, 0.1-5 parts of Fructus Hippophae extractum, 0.1-7 parts of younghusband jerusalemsage root, 0.1-6 parts of Radix Glycyrrhizae, 0.1-5 parts of Chinese prickly ash, spirit
0.1-5 parts of sesame, 0.1-2 parts of muscone.
The present invention furthermore provides a kind of Chinese medicine composition, which includes A drugs and B drugs, preferably by A
Drug and B drugs composition, wherein A drugs are made of the Chinese medicine material of following weight:1-30 parts of turnip, excrementum pteropi 10-
40 parts, 20-60 parts of myrobalan, 1-30 parts of rheum officinale, 1-30 parts of rhodiola root, 1-30 parts of Rhizoma Acori Calami, 1-30 parts of cordyceps sinensis, west safflower
0.1-15 parts, sunglo 0.1-10 parts long, 0.1-10 parts of Fructus Hippophae extractum, 0.1-10 parts of younghusband jerusalemsage root, 0.1-15 parts of Radix Glycyrrhizae, Chinese prickly ash 0.1-20
Part, 0.1-20 parts of ganoderma lucidum, 0.1-2 parts of muscone.Further preferred 10-20 parts of turnip, 20-35 parts of excrementum pteropi, myrobalan 35-50
Part, 1-15 parts of rheum officinale, 1-10 parts of rhodiola root, 1-10 parts of Rhizoma Acori Calami, 1-10 parts of cordyceps sinensis, 0.1-5 parts of west safflower, long sunglo
0.1-5 parts, it is 0.1-5 parts of Fructus Hippophae extractum, 0.1-7 parts of younghusband jerusalemsage root, 0.1-6 parts of Radix Glycyrrhizae, 0.1-5 parts of Chinese prickly ash, 0.1-5 parts of ganoderma lucidum, artificial
0.1-2 parts of Moschus.
Wherein B drugs are one or more in rhodiola root, Swertia patens, emblic, Radix Astragali, matrimony vine, preferably rhodiola root,
Radix Astragali and matrimony vine or preferably Swertia patens, emblic and Radix Astragali.
It is big ministerial drug that side, which selects west safflower, myrobalan, Radix Glycyrrhizae, turnip, younghusband jerusalemsage root, rhodiola root, muscone,.Safflower be many medicines it
This, controls the medicine of all heat symptom-complexs.Myrobalan has 17 effects that can control 20 attributes disease.Safflower, myrobalan share, and can promote patient's muscle power, together
When king's medicine and queens and princesses' medicine is assisted to strengthen therapeutic effect.Side selects younghusband jerusalemsage root to control swollen core sore, and control tuberculosis throat and do, mild-natured.Fang Xuan
Radix Glycyrrhizae is mild-natured, and change taste is cool, can all clear lung heat.Side selects rhodiola root serum lung, cough-relieving to bring down a fever, relieve pain, for treating pneumonia.Fang Xuan
The effects that resuscitation with aromatics, degrading the channel, swelling and pain relieving.Younghusband jerusalemsage root, Radix Glycyrrhizae, rhodiola root, muscone all have auxiliary king's medicine in side
The effect for the treatment of tuberculosis, while has both subdhing swelling and detoxicating, adjust Baconic, red bar with grand balance the effect of.Select turnip acrid flavour, property in side
Temperature controls Baconic's disease, grand disease, red bar raw, treats grand disease and adjusts red bar, red bar of balance with it is grand.
Rheum officinale, Rhizoma Acori Calami, Chinese prickly ash, cordyceps sinensis, ganoderma lucidum is selected to be allowed to medicine for assistant in side.Rheum officinale, which has, rushes down toxic thermal organs heat.Rhizoma Acori Calami
Effect helping digestion is dispelled grand, promotes stomach sun, and control and do not digest disease.Four medicines act all medicines in the side of drawing, and to reach lesion, simultaneously coordinating the drug actions of a prescription is made
With.All medicine compatibilities to cure mainly red bar, based on red Ba Long complication, have the effect of clearing lung-heat is hot, annex and adjust red bar, is grand with training
Balance between root makes just to liquefy and not given birth into each internal organs, tissue and blood, evil liquid for nutrition, reinvigoration, subdhing swelling and detoxicating.
For strengthen this prescription compages object wherein one side the effect of.Rhodiola root, Swertia patens, emblic may be selected to add in
In above-mentioned prescription.Rhodiola root is cold in nature, sweet in flavor, puckery.It is distributed in lung channel.Promoting blood circulation and hemostasis, removing heat from the lung to relieve cough.Belong to the work classified under drug for invigorating blood circulation and eliminating stasis
Blood emmenagogue.Swertia patens bitter is cold in nature, heat-clearing, stomach invigorating, dampness removing.Control indigestion, gastritis, jaundice, pinkeye, toothache, aphtha.It is remaining
Sweet son is cool in nature, sweet in flavor, sour, puckery.Distributed in lung channel, stomach, effect clearing heat and cooling blood, food digesting stomach fortifying, cough-relieving of promoting the production of body fluid.More than three medicines can be with
There is removing heat from the lung to relieve cough, food digesting stomach fortifying, cancer can be treated with ancillary drug.In clinical practice, there is part trouble
The physically weak gas of person is weak, and taste is caused to be damaged, and product dyspepsia, loss of appetite affects the intake of food and nutrition, exacerbates the state of an illness.
Nourishing and conditioning of this Chinese medicine composition to spleen, stomach can be enhanced by adding in these drugs, treated taste lesion, can be improved digestion
Road function, whets the appetite, and improves nutrition intake, increases the ability that body itself resists the disease.
Likewise, to strengthen therapeutic effect of this prescription to lung cancer, can also increase including Radix Glycyrrhizae, Radix Astragali, matrimony vine in prescription
Son.Said medicine has one of invigorating the spleen, qi-regulating or antitussive action.Promote object confession of ingesting during said medicine invigorating the spleen qi-regulating
Foster " first liquid " transports parts of body to and does not change evil liquid.
On the other hand, with Chinese medicine composition provided by the invention, optionally addition is suitable pharmaceutically acceptable auxiliary
Material, can prepare the Chinese medicine preparation that can adjust immune system, and method can be the Chinese medicine preparation production method of any conventional,
Produce any conventional dosage form.In view of the compliance and drug effect of patient, the preparation is preferably peroral dosage form, is more preferably dissipated
Agent, capsule or oral liquid, more preferably powder, oral liquid, most preferably powder.
The method of preparation can be:
1)Each raw material through choose it is miscellaneous after, weigh, grouping put well it is spare;
2)Each group raw material segment, pulverizes respectively, crosses No. 2 standard screens;
3)Powder is mixed to get the active constituents of medicine composition;
4)By 3)Obtained active ingredient compositions, by standard preparation process, different according to made dosage form add pharmaceutic adjuvants,
It is processed and preparation is made.
Such as, it will thus provide the Chinese medicine composition method that is prepared into powder be:The Chinese medicine composition of offer, Jiang Geyuan are provided
The segment of material medicine is pulverized, and mixing is up to powder.
For another example the Chinese medicine composition provided is prepared into the method for oral liquid:The composition provided is decocted through water, it
After concentrate decocting liquid, then add pharmaceutically acceptable corrigent, odor mask, diluent, such as sucrose, refined honey are arranged in pairs or groups therewith,
Oral liquid is made, it is filling into bottle after sterilized.How to be decocted, it then follows the general guide principle and customary means of this field,
Such as needed in prescription addition nutmeg, then decoct when, nutmeg should afterwards under.
For another example the Chinese medicine composition provided is prepared into the method for buccal tablet:By the Chinese medicine composition powder provided with
Prepare the suitable additive of tablet of buccal tablet, such as mannitol, magnesium stearate, dextrin, mixing granulation, whole grain, tabletting to obtain the final product.
In the case of no traditional Chinese medicine extraction condition, powder and buccal tablet preferably is made in the composition provided.In use,
The powder or buccal tablet by dosage standard are got it filled, are placed in sublingual administration, is at least being swallowed after ten minutes, 30 points after swallowing
Clock can drink water.
Preferably, composition each component dosage used in the present invention is:1-20 parts of turnip, 10-35 parts of excrementum pteropi, myrobalan
20-50 parts, it is 1-20 parts of rheum officinale, 1-20 parts of rhodiola root, 1-20 parts of Rhizoma Acori Calami, 1-20 parts of cordyceps sinensis, 0.1-10 parts of west safflower, long
0.1-8 parts of sunglo, 0.1-8 parts of Fructus Hippophae extractum, 0.1-7 parts of younghusband jerusalemsage root, 0.1-10 parts of Radix Glycyrrhizae, 0.1-15 parts of Chinese prickly ash, ganoderma lucidum 0.1-15
Part, 0.1-2 parts of muscone;
It is furthermore preferred that composition each component dosage used in the present invention is:10-20 parts of turnip, 20-35 parts of excrementum pteropi, myrobalan
35-50 parts, it is 1-15 parts of rheum officinale, 1-10 parts of rhodiola root, 1-10 parts of Rhizoma Acori Calami, 1-10 parts of cordyceps sinensis, 0.1-5 parts of west safflower, long
0.1-5 parts of sunglo, 0.1-5 parts of Fructus Hippophae extractum, 0.1-7 parts of younghusband jerusalemsage root, 0.1-6 parts of Radix Glycyrrhizae, 0.1-5 parts of Chinese prickly ash, 0.1-5 parts of ganoderma lucidum,
0.1-2 parts of muscone;
Involved in the present invention program to Chinese medicine be described as follows:
Turnip:Alias turnip, Orychophragmus violaceus, circle turnip, circle root, assorted cold dishes, people from northeast claim brassica napobrassica, kohlrabi, and people from Xinjiang claims Qamgur,
Latin literary fame Brassica rapa, Brassica genus Vegetable Crops of Brassica turnip subspecies can form the biennial herb plant of fleshy root.It is loose
Fleshy root is edible, and fleshy root is tender, fine and close, for stir-frying and eating, cooking.There is cultivation in Europe, Asia and America.Acrid flavour, it is warm-natured, it controls
Baconic's disease, grand disease, red bar raw, preventable disease poison.
Research shows that turnip contains following chemical composition:Saponin(e, flavonoids, carbohydrate and its glycosides, alkaloids, volatilization
Oil, phenols, tannin, amino acid, protein, sitosterol, hexadecane, β-daucosterol, Quercetin, n-dotriacontanol, oil
The aliphatic acid such as acid, linoleic acid, erucic acid, eicosenoic acid, palmitic acid and stearic acid, butyl isothiocyanate, allyl isothiocyanate,
Thio glucose glucosides etc..Turnip has effects that related with above-mentioned active ingredient.
Excrementum pteropi:Excrementum pteropi:Flying squirrel section animal trogopterus xanthipes Milne-Edwards Trogopterus xanthipes Milne-Edwards'
Excrement.Sweet in flavor and slight bitter, it is sweet in flavor after change;Cool in nature, flat, for heat-clearing, body is mended in removing toxic substances.Resin, urea, uric acid containing volume and
Retinoid substance.Animal experiments show that this product has inhibition platelet aggregation;Increase coronary blood flow effect and improve
Microcirculation;And there are resisting stress damage, enhancing immune function, gastric acid secretion inhibiting and antioxidation.
Rhizoma Acori Calami:For aroid Rhizoma Acori Calami(Acorus calamus L)Dry rhizome, there is warm stomach, anti-inflammatory
The effect of analgesic.Rhizoma Acori Calami is also known as rhizoma calami, calamus, smelly Pu, mud calamus, big calamus.Rhizoma Acori Calami complete stool containing it is a variety of effectively into
Point, rhizome contains volatile oil, and main component is α-asarone, beta-Asarone in oil, and volatile oil is also contained at other positions of herb.Separately
Still contain vitamin, palmitic acid, acorin fatty acid mixed and sugar.Modern pharmacology result of the test shows that Rhizoma Acori Calami has tranquilizing the mind town
The effects that quiet, anticonvulsion and cooling.In addition, still there are the pharmacological actions such as solution smooth muscle spasm.
Cordyceps sinensis:Section ergot fungus cordyceps sinensis colonizes in stroma and larva corpse on Hepialidae insect larvae
Complex.It is warm-natured, it is lightly seasoned.Gas is special, and mildly bitter flavor is puckery.Containing crude protein, amino acid, fat, PEARLITOL 25C, cordycepin, worm
Oxalic acid, ergosterol, Cordyceps sinensis polysaccharide, alkaloid, uracil, adenine, adenosine, vitamin B12 and lot of trace member
Element.Cordycepic acid and cordycepin are the main active substances of cordyceps sinensis.With bacteriostasis;Cytophagy can be improved, is enhanced
Cardiovascular and human body immune function, also has the function of anticancer and anti-arrhythmia etc..
West safflower:West safflower is Iridaceae crocus plant safflower(Crocus sativus L.)Drying column cap,
The crocetin contained(Crocitin), west safflower aldehyde (safranal), crocin (Crocin) and west safflower bitter principle
(Protocrocin), there is promoting blood circulation and removing blood stasis, removing pattogenic heat from the blood and toxic material from the body, resolving stagnation for tranquilization.In addition, modern technologies research shows that, west safflower has
Inhibit cancer, adjust immunity, oxidation resistant function.
Long sunglo:Long sunglo is unique national medicine medicine resource, is formed by fungi and with the algae of its symbiosis steady
Fixed symbiosis complex is referred to as lichens (Lichens), and main biological property is embodied by fungal component, because of symbiosis
Fungi dominates in relationship, therefore lichens is divided into Lichenized fungi (lichen- on taxology
formingfungi).The type of lichens is more, resists cold drought-enduring, extremely strong to the adaptability of environment, at the earth's surface with wide life
Long field, other biological is difficult to the place survived (including south and north poles) lichens can growth and breeding.Slight bitter, puckery, taste after change
It is bitter;It is cool.Effect is clearing heat and detoxicating.For lung heat, liver heat, arteries and veins is warm, the illnesss such as scorchingly hot.It can return according to the long sunglo secondary metabolite of document
Class expects that class, the cruel class of contracting, dibenzo are muttered class, the body class that continues, three Shao classes, polysaccharide and other constituents for substitution, these substances have each
The bioactivity of kind various kinds, including antibiotic, antibacterium, antiviral, anti-inflammatory, analgesia, antipyretic, antitumor, cytotoxicity, anti-good fortune
It penetrates, plant growth inhibits and insect antifeedant etc..Including such as suberone, β-amyrin, cupreol (4), 2,4- dihydroxy -3,
6- dimethylbenzoate methyl esters, barbatic acid, damp room terpene, ethyl orsellinate, beta-hydroxy-viscous mould -5- alkene, oleanolic acid (10),
(+)-usnic acid, methyl orsellinate and 4- methyl -2,6- 4-dihydroxy benzaldehydes.
Fructus Hippophae extractum:Take fructus hippophae(The ripening fruits of Elaeangnaceae plant sea-buckthorn Hippophae thamnoides L..)It is real
It after decontamination, adds water to cook, leaching supernatant liquor, residue is decocted again with a small amount of water, and filtering merges filtrate twice, is concentrated into cream
Shape.This product is dark brown brown solid or flowing soaking paste, and micro- tool gloss, solids is hard and crisp, and section is irregular.After water infiltration
It is tried with hand, it can be by hand stained yellow.Gas micro-perfume, taste are extremely sour.Containing several physiological active substances.Mainly have vitamin, protein,
Amino acid, acyl ammonia, flavonoids, carbohydrate, organic acid, steroid acid, aliphatic acid, lipid and trace element.Fructus Hippophae extractum have effects that with
Above-mentioned active ingredient is related.
Younghusband jerusalemsage root:Root tuber for labiate younghusband jerusalemsage root.9 ~ October takes root tuber, cleans, and slice dries.It is sweet in flavor;Property
It is flat, wind and heat dispersing;It is relieving cough and reducing sputum;Myogenic sore.Main anemopyretic cold;Coughing with a lot of sputum;Sore burst for a long time and does not holds back.
Radix Glycyrrhizae:Glycyrrhizic legume Glycyrrhiza uralensis Fisch., swollen fruit Radix Glycyrrhiza
The drying root and rhizome of inflata Bat. or glycyrrhiza glabra Glycyrrhiza glabra L..It is mild-natured, it is sweet in flavor.Thoughts of returning home warp,
Stomach, the spleen channel, lung channel.Invigorate the spleen and benefit qi, cough-relieving apophlegmatic, emergency analgesic therapy, mediation property of medicine.This product is mainly containing liquiritin, glycyrrhizic acid, sweet
Careless glucin, sub- cloves olefinic oxide, glycyrrhetol, 18 а-hydroxyl enoxolone, different enoxolone, Radix Glycyrrhizae coumarin, thorn awns handle
Florigen, new Licochalcone D, glycyrrhiza glabra aglycon, isolicoflavonol, triterpenoid saponin, Ingredients Such As Coumarin.Radix Glycyrrhizae in prescription
With the effect of it is related with above-mentioned active ingredient.
Chinese prickly ash:The ripe pericarp of rutaceae Chinese prickly ash Zanthoxylum bungeanum Maxim..Acrid flavour, property is rough,
It controls grand disease and enters the heart, the top grade medicine for train of thought of relaxing.Containing volatile oil, contain limonene, cumic alcohol, Geraniol etc. in oil.Pharmacological evaluation
Show that pericarp parenteral solution has analgesic, anesthetic effect;Geraniol can cause intestine in vitro to be wriggled in a small amount, largely then be allowed to inhibit;
Water decoction is to streptococcus, staphylococcus, pneumococcus, bacillus anthracis, hay bacillus, comma bacillus, paratyphosum Bacterium and green pus
Bacillus has inhibiting effect.Chinese prickly ash has effects that related with above-mentioned active ingredient in prescription.
Ganoderma lucidum:Polyporaceae plant fungi purple sesame Ganoderma sinense Zhao, Xu et Zhang or Polyporaceae
Fungi red sesame Gan.The fructification of derma lucidum (Ley-ss.ex Fr.) Karst..It is sweet in flavor, property and.Invigorating qi for tranquilization, only
Cloperastine is breathed heavily.For having no peace of mind, palpitaition of having a sleepless night, deficiency syndrome of the lung cough and asthma, consumptive disease loses heart, do not feel like eating.Containing ergot, sterol, fungi lyase
Bacterium, acidic protein, water soluble protein, amino acid, polypeptide, alkaloid and polysaccharide, triterpenoid etc..To nervous system
There is sedation;Play the role of enhancing its function to angiocarpy;There are antibechic, phlegm-dispelling functions to respiratory system;It can also improve generation
It thanks, enhances immune function;There is inhibiting effect to pneumococcus, alpha streptococcus, staphylococcus albus and Bacillus influenzae.Ganoderma lucidum has
The effect of having, is related with above-mentioned active ingredient.Ganoderma lucidum has effects that related with above-mentioned active ingredient in prescription.
Muscone:Containing muskone, and containing muscopyridine, still 11 kinds of androstane derivatives, alcohols containing cholesteric, fat, albumen
Matter, wax and inorganic salts.Experiment shows that this product has stimulating central nervous system and revival effect, can excited breathing, acceleration heartbeat, raising
Blood pressure;Effect of the adrenaline to beta receptors can be increased, and have cool in nature to the increasing action of beta- catecholamines, removing toxic substances is controlled
The effects that parasitosis, resuscitation with aromatics, degrading the channel, swelling and pain relieving.
Rhodiola root:The herb of crassulaceae plants rhodiola root Rhodiola roseaL..It is cold in nature, it is sweet in flavor, puckery.It is distributed in lung channel.Property
It is cold, it is sweet in flavor, puckery.It is distributed in lung channel.Promoting blood circulation and hemostasis, removing heat from the lung to relieve cough.Mainly containing rhodioside, tyrosol, dendrolasin, Zang Honghua aldehyde,
17 kinds of amino acid, 21 kinds of trace elements and the ingredients such as multivitamin, volatile oil, flavones, sterol, organic acid that human body needs.
Rhodiola root has effects that related with above-mentioned active ingredient in prescription.
Swertia patens:The drying herb of gentianaceae plant knurl hair Swertia patens Swertia pseudochinensis Hara.Property
It is cold, bitter.Return liver warp, stomach, large intestine channel.Clearing away damp-heat, stomach invigorating.Herb contains when medicine hardship glycosides 2%~4%, gentiamarin, and erythricine is
Bark of ash alkali, rough gentian anthraquinone, oleanolic acid, swertisin, homo-orientin, isovitexin, Folium daisy gentisin, when medicine xanthone, first
Base works as medicine xanthone, and methyl Folium daisy gentisin, to leaf when medicine xanthone, Norbellidifodin, demethyl is as medicine Xanthones
Ton ketone.Also contain chiratin, hardship is when medicine ester glycosides, amarogentin.Swertia patens have effects that related with above-mentioned active ingredient in prescription.
Emblic:(medicine is commonly used to the ripening fruits of euphorbia plant emblic Phyllan-thus emblica L. by Tibetan
Material).It is cool in nature, it is sweet in flavor, sour, puckery.Distributed in lung channel, stomach.Clearing heat and cooling blood, food digesting stomach fortifying, cough-relieving of promoting the production of body fluid.Containing tannin, wherein there is grape
Sugared nutgall tan glucoside, gallic acid, benzoaric acid, corilagin, terchebin, Chebulagic acid, chebulinic acid, He Zici
Acid, 3,6- digalloylglucoses, dry fruit 4%-9% containing glactaric acid.Pericarp contains gallic acid, phyllemblic acid, emblic phenol.Seed contains
Fixing oil about 26% contains leukotrienes 8.8%, linoleic acid 44%, 28.4 % of oleic acid, stearic acid 2.2%, palmitic acid 3.0%, Pork and beans in oily
Cool sour 1% etc..Emblic has effects that related with above-mentioned active ingredient in prescription.
Radix Astragali:Legume astragalus mongolicus Astragalus membranaceus Bge. var.mongholicus
(Bge.) root of Hsiao and Astragalus membranacus A.membranaceus (Fisch.) Bge..Slightly warm in nature, it is sweet in flavor.Converge to the spleen channel, lung
Through.Invigorating qi for strengthening superficies, diuresis, pus draining and toxin expelling, myogenic.Mainly containing ingredients such as triterpenoid saponin, flavones and polysaccharide.Water decoction tool, which is adjusted, exempts from
Epidemic disease, anti-aging and anti-stress effect.Radix Astragali has effects that related with above-mentioned active ingredient in prescription.
The fruit of Chinese wolfberry:The ripening fruits of plant of Solanaceae lycium barbarum Lycium barbarum L..It is mild-natured, it is sweet in flavor, return liver warp,
Kidney channel, nourishing liver and kidney, benefiting shrewd head.Containing polysaccharide, aliphatic acid, glycine betaine, carrotene, riboflavin, niacin, amino acid, vitamin
C and various trace elements etc..There is anti-fatty liver, anti-aging, improve immunity.The fruit of Chinese wolfberry has effects that in prescription
It is related with above-mentioned active ingredient.
The invention has the advantages that:A kind of herbal mixture buccal tablet disclosed by the invention, can effectively inhibit,
Tumour is eliminated, improves the life quality of patient.
Specific embodiment:
It is further illustrated the present invention below by way of several embodiments.It should be appreciated that cited all embodiments are to help this
Field technology personnel understand and implement the present invention, not any type of any limitation of the invention.All are in base of the present invention
The simple modifications carried out on plinth and adjustment and raw material therein is carried out to equivalent or equivalent replacement, and fail to generate new
Substantive distinguishing features and marked improvement, it should all be within protection scope of the present invention.
1 composition prescription example of embodiment
Several example prescriptions are given below, and indicate each prescription scope of application and object.It is noted that listed prescription is not
Any restriction to composition, only concrete example purposes of discussion.The card that those skilled in the art can show according to disease
Shape is different, and the constitution difference of patient is adjusted prescription, these adjustment should be equally included within protection scope of the present invention.
Prescription 1
Turnip 72g, excrementum pteropi 145g, rheum officinale 7g, rhodiola root 7g, Rhizoma Acori Calami 14g, west safflower 4g,
It is myrobalan 218g, long sunglo 4g, Fructus Hippophae extractum 4g, younghusband jerusalemsage root 4g, Radix Glycyrrhizae 4g, Chinese prickly ash 4g, cordyceps sinensis 7g, ganoderma lucidum 4g, artificial
Moschus 2g;
Prescription 2
Turnip 72g, excrementum pteropi 145g, rheum officinale 7g, rhodiola root 7g, Rhizoma Acori Calami 14g, west safflower 4g,
Myrobalan 218g, long sunglo 4g, Fructus Hippophae extractum 4g, younghusband jerusalemsage root 4g, Radix Glycyrrhizae 4g, cordyceps sinensis 7g, muscone 2g, ganoderma lucidum 30g;
Prescription 3
Turnip 72g, excrementum pteropi 145g, rheum officinale 7g, rhodiola root 7g, Rhizoma Acori Calami 14g, west safflower 4g,
Myrobalan 218g, long sunglo 4g, Fructus Hippophae extractum 4g, younghusband jerusalemsage root 4g, Radix Glycyrrhizae 4g, cordyceps sinensis 7g, muscone 2g;
Prescription 4
Turnip 72g, excrementum pteropi 145g, rheum officinale 7g, rhodiola root 7g, Rhizoma Acori Calami 14g, west safflower 4g,
It is myrobalan 218g, long sunglo 4g, Fructus Hippophae extractum 4g, younghusband jerusalemsage root 4g, Radix Glycyrrhizae 4g, Chinese prickly ash 4g, cordyceps sinensis 7g, ganoderma lucidum 4g, artificial
Moschus 2g, rhodiola root 15g, fruit of Chinese wolfberry 10g;
Prescription 5
Turnip 72g, excrementum pteropi 145g, rheum officinale 7g, rhodiola root 7g, Rhizoma Acori Calami 14g, west safflower 4g,
It is myrobalan 218g, long sunglo 4g, Fructus Hippophae extractum 4g, younghusband jerusalemsage root 4g, Radix Glycyrrhizae 4g, Chinese prickly ash 4g, cordyceps sinensis 7g, ganoderma lucidum 4g, artificial
Moschus 2g, Radix Astragali 35g, Swertia patens 8g, emblic 20g;
Prescription 6
Turnip 72g, excrementum pteropi 120g, rheum officinale 30g, rhodiola root 40g, Rhizoma Acori Calami 25g, west safflower 8g,
Myrobalan 200g, long sunglo 15g, Fructus Hippophae extractum 10g, younghusband jerusalemsage root 20g, Radix Glycyrrhizae 30g, Chinese prickly ash 4g, cordyceps sinensis 10g, ganoderma lucidum
30g, muscone 2g;
Embodiment 2
By mice lung cancer Lewis knurl pillar cells cultures, 37 DEG C, routine culture under 5% carbon dioxide, passage in average every two days is primary,
To exponential phase density 3.0*10 is prepared into physiological saline7/ ml single cell suspensions, with 75% alcohol disinfecting animal knurl table
Face and surrounding skin, aseptically remove knurl, with 0.9% sodium chloride injection with 1:1(V:V)Living cells is made in ratio
It is counted as 107The knurl tissue homogenate of/mL is inoculated on the right side of normal nude mice under armpit, every animal inoculation pvaccination 0.2mL, observation
The growing state of knurl, treats tumor volume>100mm3When, same treatment operation carry out passage inoculation, with reach 2 generations and more than
Knurl tissue homogenate operates by the same method is inoculated in oxter on the right side of formal experiment nude mice.
It is 100mm to take tumor volume3Above nude mice is grouped at random by tumor volume, every group 10, and experiment sets model pair
According to group, positive controls, prescription group administration group, by 20mL/kg gastric infusions, 1 times/day, continuous 28 days.It is seen daily during experiment
Examine the situation of the diet of animal, drinking-water, behavioral activity and knurl, the every 5 days length and widths and the weight of animals for measuring and recording knurl,
Animal is put to death at the end of experiment, knurl is removed, weighs.
Gross tumor volume and Relative tumor proliferation rate:Using the length and width of vernier caliper measurement tumour, calculate gross tumor volume T and resist
Tumor promotion evaluation index is Relative tumor proliferation rate:The standard of curative effect evaluation:T/C % >40 % are invalid;T/C %≤40% is
Effectively.
It can be obtained from experimental result, by being set up with setting up blank control group and positive drug control group and the drug of the present invention
Experimental group carry out contrast experiment.Number of animals of the administration group tumor control rate of the present invention more than 40% is significantly more than positive control
Group and blank administration group, it was demonstrated that drug has apparent inhibiting effect to the proliferation of tumour cell.
Embodiment 2
Therapy:It is buccal, once a day, one time 4, a month as a course for the treatment of.
Curative effect judging standard:
It cures:Symptom all disappears, and 2 years and does not recur above;
It is effective:The disappearance or substantially reduced of affected area pain, CT show that affected area tumour is obviously reduced;
Effectively:Affected area pain relief, CT show that affected area tumour does not continue to increase, other positions have no new tumour;
In vain:Affected area pain is not alleviated, and tumour continues to increase or shift.
Prescription 6 uses patient:Patient Tang, man, 55 years old.Main suit:It was found that lung cancer 2 months, corpus carcinosus product is 3.0*3.8cm,
Without diffusion.Patient is uncomfortable in chest, pectoralgia, cough.After receiving 6 drug treatment in June of prescription in December, 2013, Tang's state of mind is apparent
It improves, uncomfortable in chest, cough symptom is reduced.In July, 2014, hospital is gone to recheck, cancer cell object diffusion, corpus carcinosus product is contracted to 3.0*
2.5cm.Patient mental is in good condition at present, and the symptoms such as uncomfortable in chest have significantly reduced, with ordinary person's life indifference.
Prescription 3 uses patient:Wu, man, 45 years old.Long-term smoking, after appearance does not stop cough, chest pain, weight loss, symptom
Admission examination, Small Cell Lung Cancer, after receiving the treatment of prescription 33 months, the appetite of patient improves weight and rises, and cancer cell does not occur
Transfer, after the treatment of 5 months, the area of lung tumors is contracted to 3.2*3.8cm from 3.5*4.2cm.
Treatment results:10 malign lung knurl patient's symptom after taking medicine are alleviated in various degree, and symptom can significantly change after six months
It is kind, at present wherein 7 patients with knurl life span more than 3 years.
Claims (10)
1. a kind of Chinese medicine composition for preventing and treating lung cancer, which is characterized in that include the bulk pharmaceutical chemicals of following weight:It is climing
1-30 parts of cyanines, 10-40 parts of excrementum pteropi, 20-60 parts of myrobalan, 1-30 parts of rheum officinale, 1-30 parts of rhodiola root, 1-30 parts of Rhizoma Acori Calami, winter worm
Grass 1-30 parts of summer, 0.1-15 parts of west safflower, sunglo 0.1-10 parts long, 0.1-10 parts of Fructus Hippophae extractum, 0.1-10 parts of younghusband jerusalemsage root, Radix Glycyrrhizae
0.1-15 parts and selected from least one of 0.1-20 parts of Chinese prickly ash, 0.1-20 parts of ganoderma lucidum, 0.1-2 parts of muscone.
2. Chinese medicine composition according to claim 1, which is characterized in that include the bulk pharmaceutical chemicals of following weight:It is climing
1-30 parts of cyanines, 10-40 parts of excrementum pteropi, 20-60 parts of myrobalan, 1-30 parts of rheum officinale, 1-30 parts of rhodiola root, 1-30 parts of Rhizoma Acori Calami, winter worm
Grass 1-30 parts of summer, 0.1-15 parts of west safflower, sunglo 0.1-10 parts long, 0.1-10 parts of Fructus Hippophae extractum, 0.1-10 parts of younghusband jerusalemsage root, Radix Glycyrrhizae
0.1-15 parts and at least two in 0.1-20 parts of Chinese prickly ash, 0.1-20 parts of ganoderma lucidum, 0.1-2 parts of muscone.
3. Chinese medicine composition according to claim 1, which is characterized in that include the bulk pharmaceutical chemicals of following weight:It is climing
1-30 parts of cyanines, 10-40 parts of excrementum pteropi, 20-60 parts of myrobalan, 1-30 parts of rheum officinale, 1-30 parts of rhodiola root, 1-30 parts of Rhizoma Acori Calami, winter worm
Grass 1-30 parts of summer, 0.1-15 parts of west safflower, sunglo 0.1-10 parts long, 0.1-10 parts of Fructus Hippophae extractum, 0.1-10 parts of younghusband jerusalemsage root, Radix Glycyrrhizae
0.1-15 parts, 0.1-20 parts of Chinese prickly ash, 0.1-20 parts of ganoderma lucidum, 0.1-2 parts of muscone.
4. according to the Chinese medicine composition described in claim 1-3 any one, which is characterized in that raw material further includes at least one choosing
From rhodiola root, Swertia patens, emblic.
5. according to the Chinese medicine composition described in claim 1-3 any one, which is characterized in that raw material further includes at least one choosing
From Radix Astragali, the fruit of Chinese wolfberry.
6. Chinese medicine composition according to claim 3, it is characterised in that bulk pharmaceutical chemicals weight consumption is:1-20 parts of turnip, five
Clever fat 10-35 parts, 20-50 parts of myrobalan, 1-20 parts of rheum officinale, 1-20 parts of rhodiola root, 1-20 parts of Rhizoma Acori Calami, 1-20 parts of cordyceps sinensis,
0.1-10 parts of west safflower, sunglo 0.1-8 parts long, 0.1-8 parts of Fructus Hippophae extractum, 0.1-7 parts of younghusband jerusalemsage root, 0.1-10 parts of Radix Glycyrrhizae, Chinese prickly ash
0.1-15 parts, 0.1-15 parts of ganoderma lucidum, 0.1-2 parts of muscone.
7. Chinese medicine composition according to claim 3, it is characterised in that each bulk pharmaceutical chemicals weight consumption is:10-20 parts of turnip,
20-35 parts of excrementum pteropi, 35-50 parts of myrobalan, 1-15 parts of rheum officinale, 1-10 parts of rhodiola root, 1-10 parts of Rhizoma Acori Calami, cordyceps sinensis 1-10
Part, 0.1-5 parts of west safflower, sunglo 0.1-5 parts long, 0.1-5 parts of Fructus Hippophae extractum, 0.1-7 parts of younghusband jerusalemsage root, 0.1-6 parts of Radix Glycyrrhizae, Chinese prickly ash
0.1-5 parts, 0.1-5 parts of ganoderma lucidum, 0.1-2 parts of muscone.
A kind of 8. Chinese medicine preparation, which is characterized in that the Chinese medicine composition and pharmacy provided by claim 1-7 any one
Upper acceptable auxiliary material is made.
9. a kind of health food, which is characterized in that the Chinese medicine composition that claim 1-7 any one is provided, as addition
One of agent or ingredient are made.
10. the Chinese medicine composition described in claim 1-7 any one is preparing the application in treating lung-cancer medicament.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611176570.1A CN108210657A (en) | 2016-12-19 | 2016-12-19 | A kind of Chinese medicine composition for preventing and treating lung cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611176570.1A CN108210657A (en) | 2016-12-19 | 2016-12-19 | A kind of Chinese medicine composition for preventing and treating lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108210657A true CN108210657A (en) | 2018-06-29 |
Family
ID=62650733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611176570.1A Pending CN108210657A (en) | 2016-12-19 | 2016-12-19 | A kind of Chinese medicine composition for preventing and treating lung cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108210657A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2693378C1 (en) * | 2018-10-02 | 2019-07-02 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) | Pharmaceutical composition exhibiting cytotoxic effect on human bladder cancer cells |
CN111991519A (en) * | 2020-09-09 | 2020-11-27 | 浏阳利美医院有限公司 | Tibetan medicine composition for treating chronic obstructive pulmonary disease and preparation method thereof |
CN111991547A (en) * | 2020-09-23 | 2020-11-27 | 浏阳利美医院有限公司 | Tibetan medicine composition for treating pneumoconiosis and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1517121A (en) * | 2003-10-19 | 2004-08-04 | 温先敏 | Antineoplastic medicine and its preparation process |
CN102813801A (en) * | 2012-09-14 | 2012-12-12 | 措尼 | Traditional Tibetan medicine for treating cough and preparation method thereof |
CN105250675A (en) * | 2015-11-17 | 2016-01-20 | 浏阳市利美免疫力修复中心有限公司 | Traditional Chinese medicine combination for preparing medicine for treating tumour and leukemia |
-
2016
- 2016-12-19 CN CN201611176570.1A patent/CN108210657A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1517121A (en) * | 2003-10-19 | 2004-08-04 | 温先敏 | Antineoplastic medicine and its preparation process |
CN102813801A (en) * | 2012-09-14 | 2012-12-12 | 措尼 | Traditional Tibetan medicine for treating cough and preparation method thereof |
CN105250675A (en) * | 2015-11-17 | 2016-01-20 | 浏阳市利美免疫力修复中心有限公司 | Traditional Chinese medicine combination for preparing medicine for treating tumour and leukemia |
Non-Patent Citations (1)
Title |
---|
徐艳花: "二十五味肺病丸加味治疗肺内感染", 《中国民族医药杂志》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2693378C1 (en) * | 2018-10-02 | 2019-07-02 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) | Pharmaceutical composition exhibiting cytotoxic effect on human bladder cancer cells |
CN111991519A (en) * | 2020-09-09 | 2020-11-27 | 浏阳利美医院有限公司 | Tibetan medicine composition for treating chronic obstructive pulmonary disease and preparation method thereof |
CN111991547A (en) * | 2020-09-23 | 2020-11-27 | 浏阳利美医院有限公司 | Tibetan medicine composition for treating pneumoconiosis and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048933B (en) | Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
CN101695376B (en) | Health-care food for preventing diabetes | |
CN101972338B (en) | Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof | |
CN104161187B (en) | A kind of poultry Chinese herbal feed additive, preparation method and application | |
CN106310120A (en) | Wide-spectrum traditional Chinese medicine composition water agent and preparation method thereof | |
CN106362117A (en) | Traditional Chinese medicine composition capable of dispelling alcohol effect and nourishing liver and preparation method thereof | |
CN103961521A (en) | Traditional Chinese medicine composition for treating aplastic anemia and preparation method | |
CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
CN103977368B (en) | A kind of for treating sick Chinese medicine composition of numbness caused by rheumatism cold and heat and preparation method thereof | |
CN112336815A (en) | Anti-aging composition for strengthening body, preventing cancer and conditioning hypertension, hyperglycemia and hyperlipidemia and application thereof | |
CN108210657A (en) | A kind of Chinese medicine composition for preventing and treating lung cancer | |
CN106177183A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, green tea and Folium Mori | |
CN104825821A (en) | Medicine for treating diabetes and preparation method thereof | |
CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
CN104857404A (en) | Traditional Chinese medicine preparation for treating pertussis by reducing phlegm and stopping coughing | |
CN110522798A (en) | A kind of compound preparation and preparation method thereof curing mainly coronary heart disease | |
CN104206939A (en) | Kidney-tonifying tortoise herb jelly | |
CN109248265A (en) | A kind of Chinese medicine composition for treating breast cancer | |
CN104547259B (en) | A kind of Traditional Chinese medicine for decreasing blood sugar acetum | |
CN114796434A (en) | Pill for keeping healthy qi and pathogenic factors dry | |
CN108186799A (en) | Ground bone slender acanthopanax dissipates and preparation method | |
CN109248236A (en) | A kind of Chinese medicine composition for treating liver tumour | |
CN105560984A (en) | Traditional Chinese medicine composition capable of boosting qi and invigorating spleen | |
CN104800573A (en) | Chinese medicinal composition for treating liver cancer and preparation method thereof | |
CN104645222A (en) | Traditional Chinese medicine agentia for treating postpartum continuous hyperpyrexia of woman |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180629 |
|
RJ01 | Rejection of invention patent application after publication |